CUBE vs INM · P/E 25, rev $1.07B vs rev $4.9M
CubeSmart (CUBE) versus InMed Pharmaceuticals Inc (INM) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
InMed Pharmaceuticals Inc (INM) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported INM revenue for 2025-06-30 was $4.9M. Net income was -$8.2M. Revenue was up 7.5% from 2024-06-30 to 2025-06-30. INM currently screens at market cap $5.2M.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. INM currently screens at market cap $5.2M.
Not investment advice. Open the CUBE and INM stock pages for the full models.
Not investment advice.